Insulet Total Long Term Liabilities 2010-2025 | PODD
Insulet total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Insulet total long term liabilities for the quarter ending March 31, 2025 were $1.666B, a 18.94% increase year-over-year.
- Insulet total long term liabilities for 2024 were $1.348B, a 4.03% decline from 2023.
- Insulet total long term liabilities for 2023 were $1.404B, a 0.4% decline from 2022.
- Insulet total long term liabilities for 2022 were $1.41B, a 11.58% increase from 2021.
| Insulet Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $1,348 |
| 2023 | $1,404 |
| 2022 | $1,410 |
| 2021 | $1,264 |
| 2020 | $1,062 |
| 2019 | $909 |
| 2018 | $601 |
| 2017 | $572 |
| 2016 | $338 |
| 2015 | $176 |
| 2014 | $169 |
| 2013 | $121 |
| 2012 | $106 |
| 2011 | $111 |
| 2010 | $71 |
| 2009 | $91 |
| Insulet Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,666 |
| 2024-12-31 | $1,348 |
| 2024-09-30 | $1,401 |
| 2024-06-30 | $1,397 |
| 2024-03-31 | $1,401 |
| 2023-12-31 | $1,404 |
| 2023-09-30 | $1,409 |
| 2023-06-30 | $1,407 |
| 2023-03-31 | $1,403 |
| 2022-12-31 | $1,410 |
| 2022-09-30 | $1,404 |
| 2022-06-30 | $1,412 |
| 2022-03-31 | $1,408 |
| 2021-12-31 | $1,264 |
| 2021-09-30 | $1,272 |
| 2021-06-30 | $1,251 |
| 2021-03-31 | $1,069 |
| 2020-12-31 | $1,062 |
| 2020-09-30 | $940 |
| 2020-06-30 | $929 |
| 2020-03-31 | $919 |
| 2019-12-31 | $909 |
| 2019-09-30 | $1,005 |
| 2019-06-30 | $622 |
| 2019-03-31 | $615 |
| 2018-12-31 | $601 |
| 2018-09-30 | $591 |
| 2018-06-30 | $584 |
| 2018-03-31 | $577 |
| 2017-12-31 | $572 |
| 2017-09-30 | $351 |
| 2017-06-30 | $347 |
| 2017-03-31 | $342 |
| 2016-12-31 | $338 |
| 2016-09-30 | $334 |
| 2016-06-30 | $180 |
| 2016-03-31 | $179 |
| 2015-12-31 | $176 |
| 2015-09-30 | $179 |
| 2015-06-30 | $177 |
| 2015-03-31 | $178 |
| 2014-12-31 | $169 |
| 2014-09-30 | $173 |
| 2014-06-30 | $176 |
| 2014-03-31 | $123 |
| 2013-12-31 | $121 |
| 2013-09-30 | $120 |
| 2013-06-30 | $114 |
| 2013-03-31 | $108 |
| 2012-12-31 | $106 |
| 2012-09-30 | $104 |
| 2012-06-30 | $101 |
| 2012-03-31 | $113 |
| 2011-12-31 | $111 |
| 2011-09-30 | $108 |
| 2011-06-30 | $105 |
| 2011-03-31 | $72 |
| 2010-12-31 | $71 |
| 2010-09-30 | $96 |
| 2010-06-30 | $94 |
| 2010-03-31 | $100 |
| 2009-12-31 | $91 |
| 2009-09-30 | $99 |
| 2009-06-30 | $86 |
| 2009-03-31 | $85 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $20.168B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.593B | 25.64 |
| Boston Scientific (BSX) | United States | $157.132B | 37.53 |
| Stryker (SYK) | United States | $151.401B | 31.66 |
| EssilorLuxottica (ESLOY) | France | $135.007B | 0.00 |
| Medtronic (MDT) | Ireland | $118.404B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.975B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.249B | 25.26 |
| ResMed (RMD) | United States | $40.103B | 30.12 |
| GE HealthCare Technologies (GEHC) | United States | $35.152B | 16.69 |
| Agilent Technologies (A) | United States | $34.187B | 22.29 |
| Terumo (TRUMY) | Japan | $25.999B | 33.77 |
| Koninklijke Philips (PHG) | Netherlands | $24.882B | 17.46 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.166B | 12.31 |
| Baxter (BAX) | United States | $14.764B | 11.02 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.788B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.131B | 24.82 |
| Lantheus Holdings (LNTH) | United States | $4.907B | 12.38 |
| Perrigo (PRGO) | Ireland | $3.864B | 9.79 |
| Prestige Consumer Healthcare (PBH) | United States | $3.769B | 16.84 |
| Haemonetics (HAE) | United States | $3.568B | 16.25 |
| Envista Holdings (NVST) | United States | $3.503B | 29.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.180B | 23.45 |
| LeMaitre Vascular (LMAT) | United States | $1.825B | 40.79 |
| QuidelOrtho (QDEL) | United States | $1.781B | 12.25 |
| AtriCure (ATRC) | United States | $1.494B | 0.00 |
| Acuren (TIC) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.268B | 28.52 |
| AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
| Phibro Animal Health (PAHC) | United States | $1.193B | 15.25 |
| Neogen (NEOG) | United States | $1.111B | 14.22 |
| BioLife Solutions (BLFS) | United States | $1.065B | 0.00 |
| InMode (INMD) | Israel | $0.918B | 9.25 |
| Kestra Medical Technologies (KMTS) | United States | $0.871B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.851B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.707B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.690B | 0.00 |
| Valneva SE (VALN) | France | $0.646B | 0.00 |
| Evolus (EOLS) | United States | $0.622B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.09 |
| CeriBell (CBLL) | United States | $0.556B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 23.71 |
| Surmodics (SRDX) | United States | $0.458B | 0.00 |
| SNDL (SNDL) | Canada | $0.405B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.315B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.314B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.311B | 11.44 |
| Cresco Labs (CRLBF) | United States | $0.311B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.296B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.271B | 80.17 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.249B | 20.97 |
| OraSure Technologies (OSUR) | United States | $0.248B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.228B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| Biote (BTMD) | United States | $0.228B | 6.40 |
| Brainsway (BWAY) | Israel | $0.224B | 59.20 |
| Omeros (OMER) | United States | $0.210B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.202B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 15.52 |
| TriSalus Life Sciences (TLSI) | United States | $0.177B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.163B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.34 |
| TerrAscend (TSNDF) | Canada | $0.123B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.70 |
| Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Apyx Medical (APYX) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Safety Shot (SHOT) | United States | $0.085B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 14.92 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.036B | 49.14 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |